United Healthcare 2009 Annual Report Download - page 51

Download and view the complete annual report

Please find page 51 of the 2009 United Healthcare annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 137

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137

Investments
As of December 31, 2009, we had investments with a carrying value of $14.6 billion, primarily held in
marketable debt securities. Our investments are principally classified as available-for-sale and are recorded at fair
value. We exclude gross unrealized gains and losses on available-for-sale investments from earnings and report
net unrealized gains or losses, net of income tax effects, as a separate component in shareholders’ equity. We
continually monitor the difference between the cost and fair value of our investments. As of December 31, 2009,
our investments had gross unrealized gains of $493 million and gross unrealized losses of $50 million. We
evaluate investments for impairment considering the length of time and extent to which market value has been
less than cost, the financial condition and near-term prospects of the issuer as well as specific events or
circumstances that may influence the operations of the issuer and our intent to sell the security or the likelihood
that we will be required to sell the security before recovery of the entire amortized cost. For debt securities, if we
intend to either sell or determine that we will be more likely than not be required to sell a debt security before
recovery of the entire amortized cost basis or maturity of the debt security, we recognize the entire impairment in
earnings. If we do not intend to sell the debt security and we determine that we will not be more likely than not
be required to sell the debt security but we do not expect to recover the entire amortized cost basis, the
impairment is bifurcated into the amount attributed to the credit loss, which is recognized in earnings, and all
other causes, which are recognized in other comprehensive income. For equity securities, we recognize
impairments in other comprehensive income if we expect to hold the equity security until fair value increases to
at least the equity security’s cost basis and we expect that increase in fair value to occur in a reasonably
forecasted period. If we intend to sell the equity security or if we believe that recovery of fair value to cost will
not occur in the near term, we recognize the impairment in net earnings. New information and the passage of
time can change these judgments. We manage our investment portfolio to limit our exposure to any one issuer or
market sector, and largely limit our investments to U.S. government and agency securities; state and municipal
securities; mortgage-backed securities; and corporate debt obligations, substantially all of investment grade
quality. Securities downgraded below policy minimums after purchase will be disposed of in accordance with the
investment policy.
Income Taxes
Our provision for income taxes, deferred tax assets and liabilities, and uncertain tax positions reflect our
assessment of estimated future taxes to be paid on items in the consolidated financial statements. Deferred
income taxes arise from temporary differences between financial reporting and tax reporting bases of assets and
liabilities, as well as net operating loss and tax credit carryforwards for tax purposes.
We have established a net valuation allowance against certain deferred tax assets for which the ultimate
realization of future benefits is uncertain. After application of the valuation allowances, we anticipate that no
limitations will apply with respect to utilization of any of the other net deferred income tax assets. We believe
that our estimates for the valuation allowances against deferred tax assets and tax contingency reserves are
appropriate based on current facts and circumstances.
According to U.S. Generally Accepted Accounting Principles (GAAP), a tax benefit from an uncertain tax
position may be recognized when it is more likely than not that the position will be sustained upon examination,
including resolutions of any related appeals or litigation processes, based on the technical merits.
We have established an estimated liability for federal, state and non-U.S. income tax exposures that arise and
meet the criteria for accrual under U.S. GAAP. We prepare and file tax returns based on our interpretation of tax
laws and regulations and record estimates based on these judgments and interpretations. In the normal course of
business, our tax returns are subject to examination by various taxing authorities. Such examinations may result
in future tax and interest assessments by these taxing authorities. Inherent uncertainties exist in estimates of tax
contingencies due to changes in tax law resulting from legislation, regulation and/or as concluded through the
various jurisdictions’ tax court systems.
49